Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on AIS Recurrence Risk Prediction Model Using XGBoost Combined With Convolutional Neural Network Algorithm

NCT06796283 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT06796283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06796283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on AIS Recurrence Risk Prediction Model Using XGBoost Combined With Convolutional Neural Network Algorithm
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Observational
Overall status
Completed
Start date
April 26, 2021
Completion date
December 31, 2024
Enrollment
2,628 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke